Clinical practice guideline for hypotalamic-pituitary disturbances in pregnancy and the postpartum period;Guía clínica de las modificaciones hipotalamohipofisarias en el embarazo y en el período posparto

Endocrinologia y Nutricion

Volumn 55, Issue 1, 2008, Pages 29-43

  Rabinovich, Irene Halperin ^a   Alfonso, Gabriel Obiols ^a   Moreno, Alfonso Soto ^a   Vela, Elena Torres ^a   Henzi, Frederic Tortosa ^a   Bauset, Miguel Català ^a   Peral, Alberto Gilsanz ^a   Borràs, Juan Girbés ^a   Esteban, Basilio Moreno ^a   Alfonso, Antonio Picó ^a   Picó, Carlos Del Pozo ^a   Murillo, Ana Zugasti ^a   Morante, Tomás Lucas ^a   Fernández, Concha Páramo ^a   Da Sousa, César Varela ^a   Villabona Artero, Carles ^a,b  

^a Grupo de Trabajo de Neuroendocrinología

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Acromegaly; Diabetes insipidus; Hypercortisolism; Hyperthyroidism; Hypothalamic pituitary axis; Hypothyroidism; Postpartum period; Pregnancy; Prolactinoma; Secondary adrenal insufficiency

Indexed keywords

CHORIONIC GONADOTROPIN; GROWTH HORMONE; PROLACTIN; THYROID HORMONE;

ADRENAL INSUFFICIENCY; ARTICLE; CLINICAL PRACTICE; CUSHING SYNDROME; GOITER; HORMONE ACTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; PRACTICE GUIDELINE; PREGNANCY; PUERPERIUM; THYROID CARCINOMA; THYROID DISEASE; THYROID NODULE;

EID: 38549127609     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/S1575-0922(08)70633-8     Document Type: Article

References (84)

1. Schindler AE. Endocrinology of pregnancy: consequences foe the diagnosis and treatment of pregnancy disorders. J Steroid Biochem Mol Biol. 2005;97:386-8.
2. Petraglia F, D'Antona D. Maternal endocrine and metabolic adaptation to pregnancy. En: UpToDate, Rose BD, editores. Waltham: UpToDate; 2006.
3. a ed. Philadelphia: Blackwell Science; 2002. p. 628-41.
4. Scheithauer BW, Sano T, Kovacs KT, Young WF, Rgan N, Randall LV. The pituitary gland in pregnancy: a clinico-pathological and immunohistochemical study of 69 cases. Mayo Clinic Proc. 1990;65:461-74.
5. Dinc H, Esen F, Demirci A, Sari A, Resit Gamele H. Pituitary dimensions and volume measurements in pregnancy and postpartum. MR assessment. Acta Radiol. 1998;39:64-9.
6. Vidal S, Scheithauer BW, Kovacs K. Vascularity in nontumorous human pituitaries and incidental microadenomas: A morphometric study. Endocr Pathol. 2000;11:215-27.
7. Buhimschi CS. Endocrinology of lactation. Obstet Gynecol Clin North Am. 2004;31:963-79.
8. Norwitz ER. Physiology of parturition. En: Rose BD, editor. Waltham: UpToDate; 2006.
9. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18:404-33.
10. Ain KB, Mori Y, Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab. 1987;65:689-96.
11. LaFranchi S. Thyroid hormone in hypopituitarism, Graves' disease, congenital hypopituitarism & maternal thyroid disease during pregnancy. GH & IGF Res. 2006;16:S20-4.
12. Nisula BC, Ketelslegers JM. Thyroid-stimulating activity and chorionic gonadotropin. J Clin Invest. 1974;54:494-9.
13. Silvenberg J, O'Donnell J, Sugenoya A, Row VV, Volpé R. Effect of human chorionic gonadotropin on human thyroid tissue in vivo. J Clin Endocrinol Metab. 1978;46:420-4.
14. Hershman JM. Role of human chorionic gonadotropin as a thyroid stimulator. J Clin Endocrinol Metab. 1992;74:258-9.
15. Harada A, Hershman JM, Reed AW, Braunstein GD, Dignam WJ, Derzko C, et al. Comparison of thyroid stimulators and thyroid hormone concentrations in the sera of pregnant women. J Clin Endocrinol Metab. 1979;48:793-7.
16. Glinoer D, DeNayer P, Buordoux P, Lemone M, Robyn C, Van Steiteghem A, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab. 1990;71:276-87.
17. Utiger RD. Iodine nutrition - more is better. N Engl J Med. 2006;3545:2819-21.
18. Fisher DA, Klein AH. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med. 1981;304:702-12.
19. Vulsman T, Gons MH, Devijlder JJM. Maternal fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321:13-6.
20. Rasmussen NG, Hornnes PJ, Hegedus L, Feldt-Rasmussen U. Serum thyroglobulin during the menstrual cycle, during pregnancy, and post partum. Acta Endocrinol (Copenh). 1989;121:168-73.
21. Kung A, Chau M, Lao TT, Tam SC, Low LC. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab. 2002;87:1010-4.
22. Moosa M, Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab. 1997;82:2862-6.
23. Mestman JH, Goodman TM, Montoro MM. Thyroid disorders of pregnancy. Endocrinol Metab Clin North Am. 1995;24:41-71.
24. LeBeau SO, Mandel SJ. Thyroid Disorders during pregnancy. Endocrinol Metab Clin North Am. 2006;35:117-36.
25. Neale D, Burrow G. Thyroid disease and pregnancy. Obstet Gynecol Clin N Am. 2004;31:893-905.
26. Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol. 1993;81:349-53.
27. Pop VJ, Brouwers EP, Vader HL, Vulsma T, Van Baar AL, De Vijlder JJ. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol. 2003;59:282-8.
28. Kaplan M. Monitoring thyroxine treatment during pregnancy. Thyroid. 1992;2:147-52.
29. Mandel SJ, Spencer CA, Hollowell JG. Are detection and treament of thyroid insufficiency in pregnancy feasible? Thyroid. 2005;15:44-53.
30. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, GUnter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;82:489-99.
31. Stagnaro-Green A, Glinoer D. Thyroid autoimmunity and the risk of miscarriage. Best Pract Res Clin Endocrinol Metab. 2004;18:167-81.
32. Glinoer D, Riahi M, Grün J, Kinthaert J. Risk of suclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab. 1994;79:197-204.
33. Goodwin TM, Montoro M, Mestman JH, Pekari AE, Hershman JM. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab. 1992;75:1333-7.
34. Davis LE, Lucas MJ, Hankins GDV, Roark ML, Cunningham FG. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol. 1989;160:63-70.
35. Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa K. Risk factors for developmental disorders in infants born to women with Graves' disease. Obstet Gynecol. 1992;80:359-64.
36. Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y, Ninura T. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol. 1984;20:695-700.
37. Marchant B, Brownlie BE, Hart D, Horton PW, Alexander WD. The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 1977;45:1187-93.
38. Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K. Antithyroid drug therapy for Graves' disease during pregnancy. N Engl J Med. 1986;315:24-8.
39. Sherif IH, Oyan WT, Bosairi S, Carrascal SM. Treatment of hyperthyroidism in pregnancy. Acta Obstet Gynecol Scand. 1991;70:461-3.
40. Masiukiewicz US, Burrow GN. Hyperthyroidism in pregnancy: diagnosis and treatment. Thyroid. 1999;9:647-52.
41. Evans P, Webster J, Evans W, Bevan JS, Scanlon MF. Radioiodine treatments in unsuspected pregnancy. Clin Endocrinol. 1998;48:281-3.
42. Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. J Clin Endocrinol Metab. 1992;75:738-44.
43. Lindsay JR, Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy: Challenges in disease detection and treatment. Endocr Rev. 2005;26:775-99.
44. Buescher MA, McClamrock HD, Adashi EY. Cushing syndrome in pregnancy. Obstet Gynecol. 1992;79:130-7.
45. Aron DC, Schnall AM, Sheeler LR. Cushing's syndrome and pregnancy. Am J Obstet Gynecol. 1990;162:244-52.
46. Guilhaume B, Sanson ML, Billaud L, Bertagna X, Laudat MH, Luton JP. Cushing's syndrome and pregnancy: aetiologies and prognosis in twenty-two patients. Eur J Med. 1992;1:83-9.
47. Reschke K, Klose S, Mohnike K, Buhtz P, Roessner A, Lehnert H. [Manifestation of Cushing syndrome and osteoporotic fractures in pregnancy in a patient with Carney complex]. Med Klin (Munich). 2002;97:91-5.
48. Bevan JS, Gough MH, Gillmer MD, Burke CW. Cushing's syndrome in pregnancy: the timing of definitive treatment. Clin Endocrinol (Oxf). 1987;27:225-33.
49. Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK. Cushing's syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 2005;90:3077-83.
50. Lindsay JR, Nieman LK. Adrenal disorders in pregnancy. Endocrinol Metab Clin North Am. 2006;35:1-20.
51. Suda T, Iwashita M, Ushiyama T, Tozawa F, Sumitomo T, Nakagami Y, et al. Responses to corticotropinreleasing hormone and its bound and free forms in pregnant and nonpregnant women. J Clin Endocrinol Metab. 1989;69:38-42.
52. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003;88:5593-602.
53. Molitch ME. Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am. 2006;35:99-116.
54. Manzanares J, Martínez de Osaba MJ, Halperin I, Castelo-Branco C, Millan O, Vilardell E. Diagnóstico de la enfermedad de Cushing en el embarazo. Med Clin (Barc). 1995;105:744-7.
55. Doshi S, Bhat A, Lim KB. Cushing's syndrome in pregnancy. J Obstet Gynaecol. 2003;23:568-9.
56. Shaw JA, Pearson DW, Krukowski ZH, Fisher PM, Bevan JS. Cushing's syndrome during pregnancy: curative adrenalectomy at 31 weeks gestation. Eur J Obstet Gynecol Reprod Biol. 2002;105:189-91.
57. Close CF, Mann MC, Watts JF, Taylor KG. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. Clin Endocrinol (Oxf). 1993;39:375-9.
58. Amado JA, Pesquera C, Gonzalez EM, Otero M, Freijanes J, Alvarez A. Successful treatment with ketoconazole of Cushing's syndrome in pregnancy. Postgrad Med J. 1990;66:221-3.
59. Ambrosi B, Barbetta L, Morricone L. Diagnosis and management of Addison's disease during pregnancy. J Endocrinol Invest. 2003;26:698-702.
60. Albert E, Dalaker K, Jorde R, Berge LN. Addison's disease and pregnancy. Acta Obstet Gynecol Scand. 1989;68:185-7.
61. Stechova K, Bartaskova D, Mrstinova M, Cerny M, Snajderova M, Cinek O, et al. Pregnancy in a woman suffering from type 1 diabetes associated with Addison's disease and Hashimoto's Thyroidtis. Exp Clin Endocrinol Diab. 2004;112:333-7.
62. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 2002;23:327-64.
63. Chrisoulidou A, Williamson C, De Swiet M. Assessment of adrenocortical function in women taking exogenous glucoglucocorticoides during pregnancy. J Obstet Gynaecol. 2003;23:643-4.
64. Overton CE, Davis CJ, West C, Davies MC, Conway GS. High risk pregnancies in hypopituitary women. Hum Reprod. 2002;17:1464-7.
65. Mckenna DS, Wittber GM, Nagaraja HN, Samuel P. The effects of repeat doses of antenatal corticosteroids on materal adrenal function. Am J Obstet Gynaecol. 2000;183:669-73.
66. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, et al. Guidelines of the Pituitary Society for the Diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006;65:265-73.
67. Konopka P, Raimond JP, Merceron RE, Seneze J. Continous administration of bromocriptine in the prevention of the neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol. 1983;146:935-8.
68. Krupp P, Monka C. Bromocriptine in pregnancy: safety aspects. Klin Wochenschr. 1987;65:823-7.
69. Ciccarelli E, Grottoli S, Razzone P, Gaia D, Bertagna A, Cirillo S, et al. Long term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinemia and outcome of drug-induced pregnancy. 1997;20:547-51.
70. Bronstein MD, Salgado LR, De Castro Musolino NR. Medical management of pituitary adenomas: the special case of management of the pregnant woman. Pituitary. 2002;5:99-107.
71. Frankenne F, Closset J, Gomez F, Scippo ML, Smal J, Hennen G. The physiology of growth hormones (GHs) in pregnant women and partial caracterization of the placental GH variant. J Clin Endocrinol Metab. 1988;66:1171-80.
72. Colao A, Merola B, Ferone D, Lombardi G. Acromegaly. J Clin Endocrinol Metab. 1997;82:2777-81.
73. Sheehan HL. Postpartum necrosis of anterior pituitary. J Pathol Bact. 1937;45:189-214.
74. Kalistimur F. Sheehan's syndrome. Pituitary. 2003;6:181-8.
75. Hashimoto K, Takao T, Makino S. Lymphocytic adenohypophysitis and lymphocytic infundibuloneurohypophysitis. Endocr J. 1997;44:1-10.
76. Lindheimer MD, Davison JM. Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy. Eur J Endocrinol. 1995;132:133-43.
77. Barron WM, Cohen LH, Ulland LA, Lassiter WE, Fulghum EM, Emmanovel D, et al. Transient vasopressin-resistant diabetes insipidus of pregnancy. N Engl J Med. 1984;310:442-4.
78. Lindheimer MD, Barron WM, Davison JM. Osmotic and volume control of vasopressin release in pregnancy. Am J Kidney Dis. 1991;17:105.
79. Briet JW. Diabetes insipidus, Sheehan's syndrome and pregnancy. Eur J Obstet Gynecol Reprod Biol. 1998;77:201-3.
80. Leggett DA, Hill PT, Anderson RJ. "Stalkitis" in a pregnant 32-year-old woman: a rare cause of diabetes insipidus. Australas Radiol. 1999;43:104-7.
81. Durr JA. Diabetes insipidus during pregnancy. Am J Kidney Dis. 1987;9:276.
82. Brewster UC, Hayslett JP. Diabetes insipidus in the third trimestre of prengancy. Obstet Gynecol. 2005;105:1173-6.
83. Davison JM, Sheills EA, Philips PR, Barrou WM, Lindheimer MD. Metabolic clearance of vasopressin and an analogue resistant to vasopressinase in human pregnancy. Am J Physiol. 1993;264:F348.
84. Ray JG. dDAVP use during pregnancy: An analysis of its safety for mother and child. Obstet Gynecol Surv. 1998;53:450.